NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase TVTX Q1 2026 Earnings EPS Falls Short of Expectations Amid RD Focus KNSA Q1 2026 Earnings EPS Surpasses Estimates by 315 Despite Stock Decline BARK Q1 2026 Earnings Narrowing Losses Beats Street Estimates but Stock Slides PLSE Q1 2026 Earnings EPS Beat but No Revenue as Stock Declines SLMBP Q1 2026 Earnings Preferred Stock Series B Results Driven by Strong EPS Surprise